Learn About the Medical Management of Heart Failure on CME Webcast. Heart failure is an indiscriminate villain and can attack the rich and the poor, man or woman, old or young. But the good news is that we have better medical treatments for heart failure than ever before. On this CME Webcast, we’re going to update you about them. Joining our moderator in the studio are two heart failure cardiologists from the Ohio State University. Dr. Ajay Vallakati is an Assistant Professor and Dr. Brent Lampert is an Associate Professor, both from the Department of Internal Medicine.
View a video introduction of this webcast
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: UNDERSTAND the mechanism of action and indications for sacubitril-valsartan; UNDERSTAND the mechanism of action and indications for ivabradine; DISCUSS the pharmacological management of heart failure; and RECOGNIZE new heart failure therapies including sacubitril-valsartan and ivabradine as well as understand their role in treating heart failure.
You’ll also learn about the following:
- New medications to treat heart failure
- Selecting an ACE inhibitor
- Selecting a diuretic
- Diastolic versus systolic heart failure treatment
- Counseling patients about sodium and fluid intake
- When to place an automatic implantable cardiac defibrillator
- Follow-up testing of patients with heart failure
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at email@example.com.